Grow Opportunity

Topic
Psychedelics

Advertisement

Stories continue below

PsychedelicsFeaturesOpinionPsilocybin

December 18, 2023
Canada owes its veterans new mental health tools: Access to psychedelic therapies is overdue

PsychedelicsNewsBusinessPsilocybin

November 27, 2023
Lophos Pharmaceuticals Corp. Receives Health Canada approval for expanded controlled substance operations

PsychedelicsFeaturesMedicalResearch

November 17, 2023
Alberta’s policy on psychedelic drug treatment for mental illness: Will Canada lead the psychedelic renaissance?

PsychedelicsNewsRegulations

November 13, 2023
‘DULF, as we knew it, is dead’

PsychedelicsFeaturesOpinionEvents

November 10, 2023
Mark Haden and Gabor Maté talk the bright side of psychedelics

PsychedelicsNewsBusinessInternational

November 7, 2023
PharmAla completes historic first shipment of MDMA and psilocybin to Cortexa

PsychedelicsFeaturesOpinionInternational

October 19, 2023
Respecting Indigenous authority in psychedelics

PsychedelicsNewsBusinessLegal

October 10, 2023
Lophos secures controlled substance dealer’s license with the expertise of Canalytica Corp.

PsychedelicsNewsBusinessCultivation

September 5, 2023
The latest issue of Grow Opportunity has arrived

PsychedelicsFeaturesOpinionCultivation

September 1, 2023
From the Editor: Fall into five years of legal cannabis

PsychedelicsNewsLegalPsilocybin

July 17, 2023
Experts doubt whether illegal magic mushroom stores will advance drug policy

PsychedelicsNewsResearch

July 6, 2023
Neuma and SLC launch psychedelic foundations course

PsychedelicsNewsBusinessInternationalManagement

June 20, 2023
Psyched Wellness appoints new director

PsychedelicsNewsBusinessEvents

April 5, 2023
High Tide to present at Sequire Cannabis & Psychedelics Investor Conference

PsychedelicsNewsInternationalWellness

April 3, 2023
Sacred Rebels, Iquitos, Peru, opens doors to men in recovery

PsychedelicsNewsBusinessInternational

March 23, 2023
Lucy Scientific Discovery partners with High Times to develop and distribute a new line of psychoactive products

PsychedelicsNewsBusinessRegulations

March 2, 2023
HYTN Innovations expands its controlled drugs and substances dealers license to include MDMA and Ketamine